Anthracycline-Induced Cardiotoxicity in Adults
Anthracycline-Induced Cardiotoxicity in Adults | Semantic Scholar
The Cardiotoxicity of Cancer-Related Drug Therapies
Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantro
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology
Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantro
Anthracycline and their cumulative life time dose. 19-25 | Download Table
Risk factors associated with anthracycline- induced cardiotoxicity. | Download Table
Correlation between the cumulative anthracycline dose and the cardiac... | Download Scientific Diagram
Anthracycline-Induced Cardiotoxicity in Adult Hematologic Malignancies - ScienceDirect
Anthracycline-Induced Cardiotoxicity in Adults
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet). | Semantic Scholar
Learning from an anthracycline error
Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies - Annals of Oncology
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer | JACC: CardioOncology
Survivorship: Managing Cardiac Toxicities
Cumulative dose of doxorubicin | Download Table
Frontiers | Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology
Survivorship: Managing Cardiac Toxicities
crt-40-121-i001.jpg
Prevention of Anthracycline- induced Cardiotoxicity
